CEMI CEMI

Chembio Diagnostics Stock Price

0.29
-0.02 (-6.45%)
Upgrade to Real-Time
Regular Market
0.29
Volume 52,322
Bid Price 0.29
Ask Price 0.2901
News -
Day High 0.3099

Low
0.23

52 Week Range

High
2.12

Day Low 0.29
Company Name Stock Ticker Symbol Market Type
Chembio Diagnostics Inc CEMI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.02 -6.45% 0.29 12:05:34
Open Price Low Price High Price Close Price Prev Close
0.298 0.29 0.3099 0.31
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
180 52,322 $ 0.2928795 $ 15,324 - 0.23 - 2.12
Last Trade Time Type Quantity Stock Price Currency
12:47:17 1 $ 0.2901 USD

Period:

Draw Mode:

Chembio Diagnostics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 10.65M 36.71M 36.28M $ 36.93M $ -23.67M -1.42 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 7.80%

more financials information »

Chembio Diagnostics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CEMI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.2550.32610.2550.3071566212,0650.03513.73%
1 Month0.360.38990.230.2921416303,629-0.07-19.44%
3 Months0.5830.650.230.3700174569,450-0.293-50.26%
6 Months0.67871.240.230.7395156922,888-0.3887-57.27%
1 Year2.032.120.230.9141831730,744-1.74-85.71%
3 Years4.1716.200.234.552,723,566-3.88-93.05%
5 Years7.2516.200.234.581,660,223-6.96-96.0%

Chembio Diagnostics Description

Chembio Diagnostics Inc is a company that develops, manufactures, and commercializes point-of-care diagnostic tests that detect infectious diseases. The products of the company include rapid tests for the detection of HIV 1/2 antibodies and a multiplex rapid test for the detection of HIV and syphilis antibodies. The company offered rapid medical tests that are offered in Africa, Asia, Europe, and the Middle East, Latin America and the United States, of which key revenue is derived from Latin America.